VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Tuesday, December 30, 2025

Stock Comparison

The Clorox Company vs Sanofi

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

The Clorox Company

CLX · New York Stock Exchange

Market cap (USD)
SectorConsumer
CountryUS
Data as of2025-12-25
Moat score
57/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into The Clorox Company's moat claims, evidence, and risks.

View CLX analysis

Sanofi

SAN · Euronext Paris

Market cap (USD)
SectorHealthcare
CountryFR
Data as of2025-12-30
Moat score
74/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Sanofi's moat claims, evidence, and risks.

View SAN analysis

Comparison highlights

  • Moat score gap: Sanofi leads (74 / 100 vs 57 / 100 for The Clorox Company).
  • Segment focus: The Clorox Company has 9 segments (33% in Cleaning (U.S.)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
  • Moat breadth: The Clorox Company has 4 moat types across 3 domains; Sanofi has 5 across 3.

Primary market context

The Clorox Company

Cleaning (U.S.)

Market

U.S. household cleaning & disinfecting products

Geography

United States

Customer

Consumers

Role

Brand owner / manufacturer

Revenue share

33%

Sanofi

Pharma (Prescription Medicines)

Market

Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)

Geography

Global

Customer

Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)

Role

Research-based drug developer, manufacturer, and marketer

Revenue share

79.8%

Side-by-side metrics

The Clorox Company
Sanofi
Ticker / Exchange
CLX - New York Stock Exchange
SAN - Euronext Paris
Market cap (USD)
n/a
n/a
Sector
Consumer
Healthcare
HQ country
US
FR
Primary segment
Cleaning (U.S.)
Pharma (Prescription Medicines)
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
57 / 100
74 / 100
Moat domains
Demand, Supply, Legal
Legal, Supply, Demand
Last update
2025-12-25
2025-12-30

Moat coverage

Shared moat types

Brand TrustDistribution Control

The Clorox Company strengths

Compliance AdvantageInstalled Base Consumables

Sanofi strengths

Regulated Standards PipeIP Choke PointLearning Curve Yield

Segment mix

The Clorox Company segments

Full profile >

Cleaning (U.S.)

Oligopoly

33%

Professional Products (U.S.)

Oligopoly

5%

Bags and Wraps (U.S.)

Duopoly

11%

Cat Litter (U.S.)

Oligopoly

9%

Grilling (U.S.)

Oligopoly

8%

Food (U.S.)

Competitive

11%

Water Filtration (U.S.)

Oligopoly

4%

Natural Personal Care (U.S.)

Competitive

3%

International (Ex-U.S.)

Competitive

15%

Sanofi segments

Full profile >

Pharma (Prescription Medicines)

Oligopoly

79.8%

Vaccines

Oligopoly

20.2%

Opella (Consumer Healthcare - Sanofi minority stake)

Competitive

n/a

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.